Literature DB >> 32482489

Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment.

Bin Zhu1, Huiying Guo2, Ying Cao3, Ruopeng An4, Yuyan Shi5.   

Abstract

BACKGROUND: Consumers' access to cannabis has been considerably expanded in US states where recreational cannabis was legalized and commercialized. However, little is known about the important factors influencing consumers' purchase decisions in cannabis retail dispensaries. This study examined cannabis users' perceptions of the relative importance of policy-relevant factors when they made cannabis purchase decisions.
METHODS: An online survey was administered to 817 adult cannabis users in seven states in the US (California, Colorado, Maine, Massachusetts, Nevada, Oregon, and Washington) that had approved cannabis commercialization by the time of interview in January 2018. Twenty policy-relevant cannabis attributes were evaluated, including those pertaining to product characteristics, quality, package characteristics, price and free sample, store characteristics, and restrictions on use. A best-worst scaling experiment was employed, which asked respondents to select the most and the least important attributes in a choice scenario. Each respondent answered 10 choice scenarios, each including a random combination of four attributes out of the 20. The relative importance of each attribute was evaluated using hierarchical Bayesian estimation of mixed logit models.
RESULTS: Overall, 'quality', 'strain type', 'price', 'THC' (tetrahydrocannabinol) and 'pesticide' were the top five important attributes affecting cannabis users' willingness to buy cannabis in a dispensary. These five attributes jointly accounted for approximately half of the total importance. In subsample analysis, both recreational and dual-purpose users attached higher importance to 'quality', 'THC', and 'price', whereas medical users tended to think 'CBD' (cannabidiol) and 'pesticide' were more important. All cannabis users perceived 'package' to be the least important attribute. Gender had no major differences in perceptions.
CONCLUSIONS: Cannabis users in general perceived product characteristics, quality, and price to be important factors in their willingness to buy cannabis in dispensaries. There were heterogeneities in the perceptions by cannabis use purposes. The findings might deserve consideration in cannabis policy design.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behavioral Economics; Best-worst scaling; Cannabis Legalization; Consumer Preferences; Recreational Cannabis

Mesh:

Year:  2020        PMID: 32482489      PMCID: PMC7704653          DOI: 10.1016/j.drugpo.2020.102793

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  33 in total

1.  Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.

Authors:  Yuyan Shi; Di Liang; Yuhua Bao; Ruopeng An; Mark S Wallace; Igor Grant
Journal:  Drug Alcohol Depend       Date:  2018-10-25       Impact factor: 4.492

2.  State-level relationships cannot tell us anything about individuals.

Authors:  Alex H S Harris; Keith Humphreys; John W Finney
Journal:  Am J Public Health       Date:  2015-02-25       Impact factor: 9.308

3.  Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups?

Authors:  Sharon R Sznitman
Journal:  Int J Drug Policy       Date:  2017-01-18

4.  Into the void: Regulating pesticide use in Colorado's commercial cannabis markets.

Authors:  Todd Subritzky; Simone Pettigrew; Simon Lenton
Journal:  Int J Drug Policy       Date:  2017-02-04

5.  Developing public health regulations for marijuana: lessons from alcohol and tobacco.

Authors:  Rosalie Liccardo Pacula; Beau Kilmer; Alexander C Wagenaar; Frank J Chaloupka; Jonathan P Caulkins
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

6.  Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.

Authors:  F Reed Johnson; Emily Lancsar; Deborah Marshall; Vikram Kilambi; Axel Mühlbacher; Dean A Regier; Brian W Bresnahan; Barbara Kanninen; John F P Bridges
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

7.  Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample.

Authors:  Lewei A Lin; Mark A Ilgen; Mary Jannausch; Kipling M Bohnert
Journal:  Addict Behav       Date:  2016-05-17       Impact factor: 3.913

8.  The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.

Authors:  Yuyan Shi; Di Liang
Journal:  Addiction       Date:  2020-03-10       Impact factor: 6.526

Review 9.  Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review.

Authors:  Lisa M Wilson; Erika Avila Tang; Geetanjali Chander; Heidi E Hutton; Olaide A Odelola; Jessica L Elf; Brandy M Heckman-Stoddard; Eric B Bass; Emily A Little; Elisabeth B Haberl; Benjamin J Apelberg
Journal:  J Environ Public Health       Date:  2012-06-07

Review 10.  Effects of alcohol tax and price policies on morbidity and mortality: a systematic review.

Authors:  Alexander C Wagenaar; Amy L Tobler; Kelli A Komro
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 11.561

View more
  2 in total

1.  Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.

Authors:  Yuyan Shi
Journal:  Addiction       Date:  2021-01-03       Impact factor: 7.256

2.  Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.

Authors:  MaryBeth Dobbins; Mannat Rakkar; Katharine Cunnane; Sarah D Pennypacker; Kimberly G Wagoner; Beth A Reboussin; E Alfonso Romero-Sandoval
Journal:  Front Public Health       Date:  2022-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.